Aura Biosciences, Inc.
NASDAQ:AURA
10.96 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Assets: | |||||
| Current Assets: | |||||
| Cash & Cash Equivalents
| 41.082 | 121.582 | 149.063 | 17.393 | 32.449 |
| Short Term Investments
| 185.087 | 67.229 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 226.169 | 188.811 | 149.063 | 17.393 | 32.449 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 5.625 | 7.871 | 4.618 | 0.016 | 0.056 |
| Total Current Assets
| 231.794 | 196.702 | 153.704 | 18.455 | 33.346 |
| Non-Current Assets: | |||||
| Property, Plant & Equipment, Net
| 22.004 | 26.042 | 6.201 | 3.574 | 3.634 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0.768 | 0.768 | 0.125 | 0.075 | 0.075 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.509 | 0.423 | 0 | 0 | 0 |
| Total Non-Current Assets
| 23.281 | 27.233 | 6.326 | 3.649 | 3.709 |
| Total Assets
| 255.075 | 223.935 | 160.03 | 22.104 | 37.055 |
| Liabilities & Equity: | |||||
| Current Liabilities: | |||||
| Account Payables
| 1.787 | 2.921 | 2.401 | 0.611 | 2.332 |
| Short Term Debt
| 2.687 | 2.963 | 0.615 | 0.015 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 3.833 | 1.773 | 0 |
| Other Current Liabilities
| 7.883 | 4.573 | 0.423 | 0.262 | 3.816 |
| Total Current Liabilities
| 12.357 | 10.457 | 7.272 | 2.661 | 6.148 |
| Non-Current Liabilities: | |||||
| Long Term Debt
| 16.87 | 17.895 | 0.36 | 0 | 0.049 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0.083 | 128.156 | 118.264 |
| Total Non-Current Liabilities
| 16.87 | 17.895 | 0.443 | 128.156 | 118.313 |
| Total Liabilities
| 29.227 | 28.352 | 7.715 | 130.817 | 124.461 |
| Equity: | |||||
| Preferred Stock
| 0 | 0 | 160.03 | 128.076 | 118.169 |
| Common Stock
| 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -287.308 | -210.9 | -152.137 | -116.886 | -94.68 |
| Accumulated Other Comprehensive Income/Loss
| 0.539 | -0.072 | 0 | 0 | 0 |
| Other Total Stockholders Equity
| 512.617 | 406.555 | 144.422 | -119.903 | -110.895 |
| Total Shareholders Equity
| 225.848 | 195.583 | 152.315 | -108.713 | -87.406 |
| Total Equity
| 225.848 | 195.583 | 152.315 | -108.713 | -87.406 |
| Total Liabilities & Shareholders Equity
| 255.075 | 223.935 | 160.03 | 22.104 | 37.055 |